Cardiac cell therapy: boosting mesenchymal stem cells effects (Q37986552)

26 August 2017

Cardiac cell therapy: boosting mesenchymal stem cells effects (English)

1 reference

26 August 2017

mesenchymal stem cell

1 reference

E Samper

1

0 references

Antonio Diez-Juan

object named as

A Diez-Juan

series ordinal

2

0 references

Pilar Sepulveda

object named as

P Sepúlveda

series ordinal

4

0 references

author name string

J A Montero

series ordinal

3

1 reference

26 August 2017

1 June 2013

1 reference

Stem Cell Reviews and Reports

26 August 2017

1 reference

26 August 2017

9

1 reference

26 August 2017

3

1 reference

26 August 2017

266-280

1 reference

https://scigraph.springernature.com/pub.10.1007/s12015-012-9353-z

26 August 2017

0 references

cites work

Selection and treatment of candidates for heart transplantation. A statement for health professionals from the Committee on Heart Failure and Cardiac Transplantation of the Council on Clinical Cardiology, American Heart Association

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9353-Z

Left ventricular remodeling after myocardial infarction: pathophysiology and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9353-Z

Stem-cell therapy for cardiac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9353-Z

Stem and progenitor cell-based therapy in ischaemic heart disease: promise, uncertainties, and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9353-Z

Stem cells in the treatment of heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9353-Z

Adult stem cells for cardiac tissue engineering

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9353-Z

Optimizing stem cell function for the treatment of ischemic heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9353-Z

Preconditioning and stem cell survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9353-Z

Cardiac cell therapy: lessons from clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9353-Z

Stem-cell-based therapy and lessons from the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9353-Z

Electrophysiological consequence of skeletal myoblast transplantation in normal and infarcted canine myocardium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9353-Z

Autologous myoblast transplantation after myocardial infarction increases the inducibility of ventricular arrhythmias.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9353-Z

Malignant tumor formation after transplantation of short-term cultured bone marrow mesenchymal stem cells in experimental myocardial infarction and diabetic neuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9353-Z

What is the oncologic risk of stem cell treatment for heart disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9353-Z

Cell therapy for the treatment of coronary heart disease: a critical appraisal

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9353-Z

From the laboratory bench to the patient's bedside: an update on clinical trials with mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9353-Z

A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9353-Z

Intramyocardial stem cell injection in patients with ischemic cardiomyopathy: functional recovery and reverse remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9353-Z

Multilineage potential of adult human mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9353-Z

Cultured adherent cells from marrow can serve as long-lasting precursor cells for bone, cartilage, and lung in irradiated mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9353-Z

In vitro cartilage formation by human adult stem cells from bone marrow stroma defines the sequence of cellular and molecular events during chondrogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9353-Z

Marrow stromal cells as stem cells for nonhematopoietic tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9353-Z

Human mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplantation in sheep

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9353-Z

Comparison of human stem cells derived from various mesenchymal tissues: superiority of synovium as a cell source.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9353-Z

Fibroblast Colony Formation from Monolayer Cultures of Blood Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9353-Z

Circulating skeletal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9353-Z

Multilineage cells from human adipose tissue: implications for cell-based therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9353-Z

Postnatal human dental pulp stem cells (DPSCs) in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9353-Z

Evidence for tissue-resident mesenchymal stem cells in human adult lung from studies of transplanted allografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9353-Z

Mesenchymal progenitor cells in human umbilical cord blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9353-Z

Different populations and sources of human mesenchymal stem cells (MSC): A comparison of adult and neonatal tissue-derived MSC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9353-Z

Mesenchymal stem cells and their use as cell replacement therapy and disease modelling tool.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9353-Z

Telomerase expression extends the proliferative life-span and maintains the osteogenic potential of human bone marrow stromal cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9353-Z

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9353-Z

Mesenchymal stem cells avoid allogeneic rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9353-Z

Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9353-Z

Immune modulation by mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9353-Z

Immunosuppression by mesenchymal stromal cells: from culture to clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9353-Z

Donor-derived mesenchymal stem cells are immunogenic in an allogeneic host and stimulate donor graft rejection in a nonmyeloablative setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9353-Z

Paracrine mechanisms of stem cell reparative and regenerative actions in the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9353-Z

Repair mechanisms of bone marrow mesenchymal stem cells in myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9353-Z

The inflammatory response in myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9353-Z

Innate immune signaling in cardiac ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9353-Z

Inflammatory cytokines and postmyocardial infarction remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9353-Z

The inflammatory response and cardiac repair after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9353-Z

Molecular mechanisms involved in mesenchymal stem cell migration to the site of acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9353-Z

Functional expression of HGF and HGF receptor/c-met in adult human mesenchymal stem cells suggests a role in cell mobilization, tissue repair, and wound healing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9353-Z

TNF-alpha enhances engraftment of mesenchymal stem cells into infarcted myocardium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9353-Z

Characterization and functionality of cell surface molecules on human mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9353-Z

Enforced hematopoietic cell E- and L-selectin ligand (HCELL) expression primes transendothelial migration of human mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9353-Z

Xenoreactivity and engraftment of human mesenchymal stem cells transplanted into infarcted rat myocardium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9353-Z

Magnetic resonance imaging overestimates ferumoxide-labeled stem cell survival after transplantation in the heart.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9353-Z

Allogeneic mesenchymal stem cells restore cardiac function in chronic ischemic cardiomyopathy via trilineage differentiating capacity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9353-Z

Bone marrow mesenchymal stem cells stimulate cardiac stem cell proliferation and differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9353-Z

Effective engraftment but poor mid-term persistence of mononuclear and mesenchymal bone marrow cells in acute and chronic rat myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9353-Z

A quantitative, randomized study evaluating three methods of mesenchymal stem cell delivery following myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9353-Z

The association of silicon microparticles with endothelial cells in drug delivery to the vasculature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9353-Z

Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9353-Z

Composite scaffold provides a cell delivery platform for cardiovascular repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9353-Z

Evaluation of alginate microspheres for mesenchymal stem cell engraftment on solid organ.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9353-Z

Homing and differentiation of mesenchymal stem cells delivered intravenously to ischemic myocardium in vivo: a time-series study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9353-Z

Mesenchymal stem cells overexpressing Akt dramatically repair infarcted myocardium and improve cardiac function despite infrequent cellular fusion or differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9353-Z

Cardiac differentiation is driven by NKX2.5 and GATA4 nuclear translocation in tissue-specific mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9353-Z

Paracrine mechanisms in adult stem cell signaling and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9353-Z

Multipotent human stromal cells improve cardiac function after myocardial infarction in mice without long-term engraftment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9353-Z

"Stemness" does not explain the repair of many tissues by mesenchymal stem/multipotent stromal cells (MSCs).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9353-Z

VEGF/SDF-1 promotes cardiac stem cell mobilization and myocardial repair in the infarcted heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9353-Z

Improved function and myocardial repair of infarcted heart by intracoronary injection of mesenchymal stem cell-derived growth factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9353-Z

Vascular endothelial growth factor (VEGF) as a key therapeutic trophic factor in bone marrow mesenchymal stem cell-mediated cardiac repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9353-Z

Genetic modification of mesenchymal stem cells overexpressing CCR1 increases cell viability, migration, engraftment, and capillary density in the injured myocardium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9353-Z

Over-expression of CXCR4 on mesenchymal stem cells augments myoangiogenesis in the infarcted myocardium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9353-Z

IGF-1-overexpressing mesenchymal stem cells accelerate bone marrow stem cell mobilization via paracrine activation of SDF-1alpha/CXCR4 signaling to promote myocardial repair.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9353-Z

A promising strategy for the treatment of ischemic heart disease: Mesenchymal stem cell-mediated vascular endothelial growth factor gene transfer in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9353-Z

Myocardial injection with GSK-3β-overexpressing bone marrow-derived mesenchymal stem cells attenuates cardiac dysfunction after myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9353-Z

Forced myocardin expression enhances the therapeutic effect of human mesenchymal stem cells after transplantation in ischemic mouse hearts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9353-Z

sFRP2 suppression of bone morphogenic protein (BMP) and Wnt signaling mediates mesenchymal stem cell (MSC) self-renewal promoting engraftment and myocardial repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9353-Z

Secreted Frizzled-related protein 2 is a procollagen C proteinase enhancer with a role in fibrosis associated with myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9353-Z

The Wnt modulator sFRP2 enhances mesenchymal stem cell engraftment, granulation tissue formation and myocardial repair.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9353-Z

Supportive interaction between cell survival signaling and angiocompetent factors enhances donor cell survival and promotes angiomyogenesis for cardiac repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9353-Z

Stable therapeutic effects of mesenchymal stem cell-based multiple gene delivery for cardiac repair.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9353-Z

Impact of anti-apoptotic and anti-oxidative effects of bone marrow mesenchymal stem cells with transient overexpression of heme oxygenase-1 on myocardial ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9353-Z

Over-expression of HO-1 on mesenchymal stem cells promotes angiogenesis and improves myocardial function in infarcted myocardium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9353-Z

Overexpression of phosphoinositide-3-kinase class II alpha enhances mesenchymal stem cell survival in infarcted myocardium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9353-Z

Connexin43 promotes survival of mesenchymal stem cells in ischaemic heart.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9353-Z

Locally overexpressing hepatocyte growth factor prevents post-ischemic heart failure by inhibition of apoptosis via calcineurin-mediated pathway and angiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9353-Z

Hepatocyte growth factor or vascular endothelial growth factor gene transfer maximizes mesenchymal stem cell-based myocardial salvage after acute myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9353-Z

Effects of myocardial transplantation of marrow mesenchymal stem cells transfected with vascular endothelial growth factor for the improvement of heart function and angiogenesis after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9353-Z

Hypoxia-inducible vascular endothelial growth factor-engineered mesenchymal stem cells prevent myocardial ischemic injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9353-Z

Integrin-linked kinase is required in hypoxic mesenchymal stem cells for strengthening cell adhesion to ischemic myocardium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9353-Z

Tissue transglutaminase is essential for integrin-mediated survival of bone marrow-derived mesenchymal stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9353-Z

Structure and function of VEGF/VEGF-receptor system involved in angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9353-Z

FGF and VEGF function in angiogenesis: signalling pathways, biological responses and therapeutic inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9353-Z

A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9353-Z

TGF-beta signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9353-Z

The many faces of hepatocyte growth factor: from hepatopoiesis to hematopoiesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9353-Z

PDGF signaling in cells and mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9353-Z

Angiopoietin-1 induces sprouting angiogenesis in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9353-Z

Paracrine factors released by GATA-4 overexpressed mesenchymal stem cells increase angiogenesis and cell survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9353-Z

Transplantation with survivin-engineered mesenchymal stem cells results in better prognosis in a rat model of myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9353-Z

Transplantation of genetically engineered mesenchymal stem cells improves cardiac function in rats with myocardial infarction: benefit of a novel nonviral vector, cationized dextran.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9353-Z

Mesenchymal stem cells modified with angiopoietin-1 improve remodeling in a rat model of acute myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9353-Z

IL-18 binding protein-expressing mesenchymal stem cells improve myocardial protection after ischemia or infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9353-Z

Notch1 in bone marrow-derived cells mediates cardiac repair after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9353-Z

TNFR gene-modified mesenchymal stem cells attenuate inflammation and cardiac dysfunction following MI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9353-Z

Isolation of multipotent adult stem cells from the dermis of mammalian skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9353-Z

Mesenchymal stem cell adhesion to cardiac microvascular endothelium: activators and mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9353-Z

Bcl-2 Engineered MSCs Inhibited Apoptosis and Improved Heart Function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9353-Z

Therapeutic potential of angiogenin modified mesenchymal stem cells: angiogenin improves mesenchymal stem cells survival under hypoxia and enhances vasculogenesis in myocardial infarction

21 January 2018

1 reference

12 December 2020

Mesenchymal stem cells modified with stromal cell-derived factor 1 alpha improve cardiac remodeling via paracrine activation of hepatocyte growth factor in a rat model of myocardial infarction

1 reference

12 December 2020

Intracoronary transplantation of autologous bone marrow mesenchymal stem cells for ischemic cardiomyopathy due to isolated chronic occluded left anterior descending artery.

1 reference

12 December 2020

Seminars in medicine of the Beth Israel Deaconess Medical Center. Insulin-like growth factors

1 reference

12 December 2020

The effects of mesenchymal stem cells transduced with Akt in a porcine myocardial infarction model

1 reference

12 December 2020

Skeletal myoblast transplantation in ischemic heart failure: long-term follow-up of the first phase I cohort of patients.

1 reference

12 December 2020

Transplantation of angiogenin-overexpressing mesenchymal stem cells synergistically augments cardiac function in a porcine model of chronic ischemia

1 reference

12 December 2020

Treatment of myocardial ischemia with bone marrow-derived mesenchymal stem cells overexpressing hepatocyte growth factor

1 reference

12 December 2020

Comparative characteristics of mesenchymal stem cells from human bone marrow, adipose tissue, and umbilical cord blood

1 reference

12 December 2020

Improved graft mesenchymal stem cell survival in ischemic heart with a hypoxia-regulated heme oxygenase-1 vector

1 reference

12 December 2020

Cytokine expression by human marrow-derived mesenchymal progenitor cells in vitro: effects of dexamethasone and IL-1 alpha

1 reference

12 December 2020

Multipotent mesenchymal stem cells from adult human synovial membrane

1 reference

12 December 2020

Effects of heme oxygenase-1 gene modulated mesenchymal stem cells on vasculogenesis in ischemic swine hearts

1 reference

12 December 2020

Transfection of mesenchymal stem cells with the FGF-2 gene improves their survival under hypoxic conditions

1 reference

12 December 2020

Mesenchymal stem cells overexpressing MiR-126 enhance ischemic angiogenesis via the AKT/ERK-related pathway.

1 reference

12 December 2020

Allogeneic marrow stromal cells are immune rejected by MHC class I- and class II-mismatched recipient mice

1 reference

12 December 2020

Bone marrow stem cells prevent left ventricular remodeling of ischemic heart through paracrine signaling

1 reference

12 December 2020

Amniotic fluid as a novel source of mesenchymal stem cells for therapeutic transplantation

1 reference

12 December 2020

Cells isolated from adult human skeletal muscle capable of differentiating into multiple mesodermal phenotypes.

1 reference

12 December 2020

Human mesenchymal stem cell-conditioned medium improves cardiac function following myocardial infarction

1 reference

12 December 2020

Hsp20-engineered mesenchymal stem cells are resistant to oxidative stress via enhanced activation of Akt and increased secretion of growth factors

1 reference

12 December 2020

Characterization of key mechanisms in transmigration and invasion of mesenchymal stem cells

1 reference

12 December 2020

Cardiac remodeling by fibrous tissue after infarction in rats

1 reference

12 December 2020

Cardiac cell therapy--mixed results from mixed cells

1 reference

12 December 2020

The in vitro migration capacity of human bone marrow mesenchymal stem cells: comparison of chemokine and growth factor chemotactic activities

1 reference

12 December 2020

SDF-1 expression by mesenchymal stem cells results in trophic support of cardiac myocytes after myocardial infarction

1 reference

12 December 2020

Mesenchymal stem cell implantation in a swine myocardial infarct model: engraftment and functional effects

1 reference

12 December 2020

Rationale and design of the Transendocardial Injection of Autologous Human Cells (bone marrow or mesenchymal) in Chronic Ischemic Left Ventricular Dysfunction and Heart Failure Secondary to Myocardial Infarction (TAC-HFT) trial: A randomized, double

1 reference

12 December 2020

A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction

1 reference

12 December 2020

Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement

1 reference

12 December 2020

Adult-Derived Human Liver Mesenchymal-Like Cells as a Potential Progenitor Reservoir of Hepatocytes?

1 reference

12 December 2020

Transforming growth factor beta signal transduction.

1 reference

12 December 2020

Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart

1 reference

12 December 2020

Interleukin-6: an overview

1 reference

12 December 2020

AKT-modified autologous intracoronary mesenchymal stem cells prevent remodeling and repair in swine infarcted myocardium.

1 reference

12 December 2020

Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta

1 reference

12 December 2020

In vivo therapy of myocardial infarction with mesenchymal stem cells modified with prostaglandin I synthase gene improves cardiac performance in mice

1 reference

12 December 2020

Precursors for fibroblasts in different populations of hematopoietic cells as detected by the in vitro colony assay method

1 reference

12 December 2020

HO-1 modified mesenchymal stem cells modulate MMPs/TIMPs system and adverse remodeling in infarcted myocardium

1 reference

12 December 2020

Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts

1 reference

12 December 2020

Apoptotic and necrotic myocyte cell deaths are independent contributing variables of infarct size in rats.

1 reference

12 December 2020

Targeted migration of mesenchymal stem cells modified with CXCR4 gene to infarcted myocardium improves cardiac performance

1 reference

12 December 2020

Fibroblast growth factors and their receptors

1 reference

12 December 2020

Paracrine action enhances the effects of autologous mesenchymal stem cell transplantation on vascular regeneration in rat model of myocardial infarction

1 reference

12 December 2020

Enhancement of the survival of engrafted mesenchymal stem cells in the ischemic heart by TNFR gene transfection

1 reference

12 December 2020

Mesenchymal Stem Cells Provide Better Results Than Hematopoietic Precursors for the Treatment of Myocardial Infarction

1 reference

12 December 2020

10.1007/S12015-012-9353-Z

Identifiers

DOI

1 reference

26 August 2017

1 reference

PubMed ID

22350458